title: [Therapy sequence for renal cell carcinoma--new aspects!].
abstract: Retroperitoneal haemorrhages mostly occur as a result of trauma. Besides a traumatic origin of retroperitoneal haemorrhage, the other most common cause is an anticoagulation therapy. Further potential sources of retroperitoneal hematoma are benign and malignant tumours of the adrenal gland.
authors.affiliation: Urologische Klinik, Universitätsklinikum Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin. kurt.miller@charite.de
authors.forename: K
authors.initials: K
authors.lastname: Miller
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001557:Benzenesulfonates / Q000008:administration & dosage; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D003131:Combined Modality Therapy; D017277:Drug Approval; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D010865:Pilot Projects; D011725:Pyridines / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D000077157:Sorafenib; D013792:Thalidomide / Q000008:administration & dosage*
chemical_list: D001557:Benzenesulfonates; D007376:Interleukin-2; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D013792:Thalidomide; D000077157:Sorafenib